Drug Approval | September 29, 2023
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
The delegation's visit covered a wide range of topics
The delegation's visit covered a wide range of topics
The product is expected to start contributing meaningfully to the revenue from FY25
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
The non-enzymatic electrochemical sensing strip can simultaneously detect the direct and total bilirubin in a single drop of blood, and provide the concentrations within a minute
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The generous donation includes multiple medical equipments
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Subscribe To Our Newsletter & Stay Updated
